Abstract
This paper examines a case of pleomorphic primitive neuroectodermal tumor (PNET) with glial and neuronal differentiation in a 7-year-old girl who was clinicopathologically reported with immunohistochemical and chromosomal analysis. Clinically, a highly aggressive behavior leading to early recurrence with cerebrospinal fluid seedings was characteristic despite total removal and chemoradiation therapy. Pathologically, severe pleomorphism was noted and large ganglioid cells were predominant.
Immunohistochemically, the expression of low-molecular neurofilament was recognized in the surgical specimens and increased in the recurrence. Coexpression of vimentin and neurofilament/GFAP was recognized in the culture. Chromosomal analysis showed near-diploidy, but different karyotype from that PNETs previously reported. These findings suggested that PNETs with pleomorphism and differentiation into both glial and neuronal lineages may show aggressiveness and require more aggressive therapy.
Similar content being viewed by others
References
Becker LE, Hinton D: Primitive neuroectodermal tumors of the central nervous system. Hum Pathol 14: 538–550, 1983
Hart MN, Earle KM: Primitive neuroectodermal tumors of the brain in children. Cancer 32: 890–897, 1973
Rorke LB: The cerebral medulloblastoma and its relationship to primitive neuroectodermal tumors. J Exp Neuropathol Exp Neurol 42: 1–15, 1983
Rorke LB, Gilles FH, Davis RL, Becker LE: Revision of the world health organization classification of brain tumors for childhood brain tumors. Cancer 56: 1869–1886, 1985
Rorke LB, Trojanowski JQ, Lee VM, Zimmerman RA, Sutton LN, Biegel JA, Goldwein JW, Packer RJ: Primitive neuroectodermal tumors of the central nervous system. Brain Pathol 7: 765–784, 1997
Seabright M: A rapid banding technique for human chromosomes (Letter). Lancet 2: 971–972, 1971
Burger PC, Scheithauer BW: Tumors of the central nervous system. In: Rosai J, Sobin LH (eds) Atlas of Tumor Pathology, 3rd series, Fascicle 10, AFIP, Washington, DC, 1993, pp 1–7
Russel DS, Rubinstein LJ: Pathology of the Nervous System, 5th edn, Edward Arnold, London, 1989, pp 219–226
Miller DC, Koslow M, Budzilovich GN, Burstein DE: Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms. Hum Pathol 21: 271–276, 1990
Chou SM, Anderson JS: Review primary central nervous system malignant rhabdoid tumor: report of two cases and review of literature. Clin Neuropathol 10: 1–10, 1991
Rorke LB, Packer R, Biegel JA: Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85: 56–65, 1996
The Committee of Brain Tumor Registry of Japan: Brain Tumor Registry of Japan (Japanese), Vol. 9, 1996, p 20
Tohyama T, Lee VMY, Trojanowski JQ: Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142: 883–892, 1993
Trojanowski JQ, Lee VMY, Schlaepfer WW: An immunohistochemical study of human central and peripheral nervous system tumors, using monoclonal antibodies against neurofilaments and glial filaments. Hum Pathol 15: 248–257, 1984
Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M: MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67: 1886–1893, 1991
Harris MD, Moore IE, Steart PV, Weller RO: Protein gene product(PGP) 9.5 as a reliable marker in primitive neuroectodermal tumours-an immunohistochemical study of 21 childhood cases. Histopathology 16: 271–277, 1990
Cruz-Sanchez FF, Rossi ML, Hughes JT, Moss TH: Differentiation in embryonal neuroepithelial tumors of the central nervous system. Cancer 67: 965–976, 1991
Gould VE, Jansson DS, Molenaar WM, Rorke LB, Trjanowski JQ, Lee VM-Y, Packer RL, Franke WW: Primitive neuroectodermal tumors of the central nervous system: patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab Invest 62: 498–508, 1990
Grant JW, Steart PV, Gallagher PJ: Primitive neuroectodermal tumors of the cerebrum: a histological and immunohistochemical study of 10 cases. Clinical Neuropathol 7(5): 228–233, 1988
Molenaar WM, Jansson DS, Gould VE, Rorke LB, Franke WW, Lee VMY, Packer RJ, Trojanowski JQ: Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest 61(6): 635–643, 1989
Fults D, Pedone CA, Morse HG, Rose JW, McKay RDG: Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere. J Neuropathol Exp Neurol 51(3): 272–280, 1992
Karnes PS, Raffel C: Pediatric brain tumors. Molecular Genetics of Nervous System Tumors, Wiley-Liss Inc., New York, 1993, pp 217–221
Albright AL, Wisoff JH, Zelter P, Boyett J, Rorke LB, Stanley P, Geyer JR, Milstein JM: Prognostic factors in children with supratentorial primitive neuroectodermal tumors. A neurosurgical perspective from the Children's Cancer Group. Pediatr Neurosurg 22: 1–7, 1995
Ashwal S, Hinshaw DB, Bedros A: CNS primitive neuroectodermal tumors of childhood. Med Ped Oncol 12: 180–188, 1984
Dirks PB, Harris L, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT: Supratentorial primitive neuroectodermal tumors in children. J Neuro-Oncol 29: 75–84, 1996
Parker JC Jr, Mortara RH, McCloskey JJ: Biological behavior of the primitive neuroectodermal tumors: significant supratentorial childhood gliomas. Surg Neurol 4: 383–388, 1975
Tomita T, McLone DG, Yasue M: Cerebral primitive neuroectodermal tumors in childhood. J Neuro-Oncol 6: 233–243, 1988
Gaffney CC, Sloane JP, Bradley NJ, Bloom HJG: Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment. J Neuro-Oncol 3: 23–33, 1985
Caputy AJ, McCullough DC, Manz HJ, Patterson K, Hammock MK: Areviewof the factors influencing the prognosis of medulloblastoma: the importance of cell differentiation. J Neurosurg 66: 80–87, 1987
Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G, Zorzi F, Montaldi A: Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 16: 687–693, 1992
Giordana MT, Cavalla P, Chio A, Marino S, Soffietti R, Vigliani MC, Schiffer D: Prognostic factors in adult medulloblastoma. A clinicopathological study. Tumori 81: 338–346, 1995
GoldbergStern H, Gadoth N, Stern S, Cohen IJ, Zaizov R, Sandbank U: The prognostic significance of glial fibrillary acidic protein staining in medulloblastoma. Cancer 68: 568–573, 1991
Janss AJ, Yachnis AT, Silber JH, Trojanowski JQ, Lee VM, Sutton LN, Perilongo G, Rorke LB, Phillips PC: Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann Neurol 39: 481–489, 1996
Packer RJ, Sutton LN, Rorke Lb, Littman PA, Sposto R, Rosenstock JG, Bruce DA, Schut L: Prognostic importance of cellular differentiation in medulloblastoma of childhood. J Neurosurg 61: 296–301, 1984
Schofield DE, Yunis EJ, Geyer JR, Albright AL, Berger MS, Taylor SR: DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system. Cancer 69: 1307–1314, 1992
Biegel JA, Rorke LB, Janss AJ, Sutton LN, Parmiter AH.: Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 14: 85–96, 1995
Bayani J, Zielenska M, Marrano P, Kwan NgY, Taylor MD, Jay V, Rutka JT, Squire JA: Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg 93: 437–448, 2000
Jay V, Squire J, Bayani J, Alkhani AM, Rutka JT, Zielenska M: Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybidization. Pathology 31: 337–344, 1999
Reardon DA, Jenkins JJ, Sublett JE, Burger PC, Kun LK: Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma. Ped Neurosurg 32: 187–191, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uematsu, Y., Takehara, R., Shimizu, M. et al. Pleomorphic Primitive Neuroectodermal Tumor with Glial and Neuronal Differentiation: Clinical, Pathological, Cultural, and Chromosomal Analysis of a Case. J Neurooncol 59, 71–79 (2002). https://doi.org/10.1023/A:1016321030590
Issue Date:
DOI: https://doi.org/10.1023/A:1016321030590